Laparoscopic power morcellators are surgical tools used to break tissue down into smaller pieces for easier removal. Doctors sometimes use morcellators to assist in minimally invasive surgeries hysterectomies (partial or complete uterus removal) and myomectomies (removing uterine fibroids), as it was believed such procedures reduce post-operative recovery time and minimize the risk of infection.
Approved power morcellators that have gynecologic indications (used for morcellating and extracting tissue from the uterus) include:
However, the FDA has estimated that 1 in 350 women who had a hysterectomy or myomectomy for fibroid treatment also had undetected leiomyosarcoma and other forms of uterine cancer. As the morcellator breaks down a malignant tumor, it can spread cancerous particles throughout the abdomen. This may make the cancer more difficult to treat and significantly reduce a patient’s chances of long-term survival.
Our firm is at the forefront of the power morcellator multidistrict litigation, with Kaiser Gornick partner Dennis Canty’s recent appointment to the Plaintiff's Steering Committee. To learn more about Morcellators and recovering compensation for your injuries, click here.
In July 30, 2014 one manufacturer of various Morcellator products recalled the devices because they were associated with the possible spread of cancerous tissues. Months prior to the recall, the FDA had strongly warned of the dangers and discouraged the use of morcellators in hysterectomies and myomectomies. In update on November 24, 2014, the FDA required a black box warning about the risk of cancer spread with the use of the device in such procedures.
If you have had a hysterectomy or myomectomy and have been diagnosed with uterine cancer, contact one of our experienced morcellator attorneys at Kaiser Gornick LLP to explore your options.